A phase 3 trial of androgen ablation vs. chemo/hormonal therapy as initial treatment of unresectable/metastatic adenocarcinoma of the prostate
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antiandrogens; Antineoplastics; Bicalutamide; Doxorubicin; Estramustine phosphate sodium; Flutamide; Hydrocortisone; Ketoconazole; Nilutamide; Vinblastine
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Oct 2018 Biomarkers information updated
- 27 Sep 2010 Actual end date (Jun 2005) added as reported by ClinicalTrials.gov.
- 27 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.